Bill Reiland is a Managing Director and Chief Investment Officer of North Haven Expansion Credit and a Managing Director of Morgan Stanley based in New York. Over the course of his 35 years of experience, Mr. Reiland has invested, structured, and marketed over 100 credit and equity transactions representing over $10Bn. Mr. Reiland initially joined Morgan Stanley in 1993 and became Head of Morgan Stanley’s Global High Yield Debt Research department in 2001. Mr. Reiland was ranked as the top health care high-yield research analyst by Institutional Investor in 2000, 2001 and 2002. In 2006, Mr. Reiland joined MSPI where he led and executed private investments on behalf of Morgan Stanley. Mr. Reiland led investments in several of MSPI’s most successful investments, including JHP Pharmaceuticals and Grifols SA. In 2008, Mr. Reiland left Morgan Stanley and joined Leerink Swann, where he was responsible for originating, structuring and marketing debt securities. In 2013, Mr. Reiland became a partner at Oberland Capital Management, a structured fixed income and equity royalty fund. Mr. Reiland rejoined Morgan Stanley in 2014 to lead the North Haven Expansion Credit effort. Mr. Reiland’s experience also includes time at Bain & Co., Stanford Hospital, Cowen and Co., and Stifel Nicholas. Mr. Reiland graduated with a B.A. in Economics from Yale University and an MBA, with distinction, from the Tuck School of Graduate Business Administration, where he was a Tuck Scholar.
Bill is a member of the Morgan Stanley Expansion Capital

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.


Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.

Subscriptions    •    Privacy & Cookies    •    Your Privacy Choices Your Privacy Choices Icon    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037